knowcompoundspterostilbene
Specimen compound organic compoundPlate I
Pterostilbene

- Formula
- C16H16O3
- Molar mass
- 256.301 g/mol
- ChEBI
- CHEBI:8630
- PubChem CID
- 5281727
- InChIKey
- VLEUZFDZJKSGMX-ONEGZZNKSA-N
↓ lowered 2 findings in 2 endpoints · – no difference found 7 in 7
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 9
- Limited
- 0
- Very limited
- 0
- Insufficient
- 0
Pterostilbene
Most findings
- Alanine aminotransferase×1
- Aspartate aminotransferase×1
- Diastolic blood pressure×1
- Gamma-glutamyl transferase×1
Show the remaining 5Show the first 4
- Serum creatinine concentration×1
- Serum potassium concentration×1
- Serum sodium concentration×1
- Serum uric acid×1
- Systolic blood pressure×1
36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
- Alanine aminotransferase
- Aspartate aminotransferase
- Diastolic blood pressure
- Gamma-glutamyl transferase
- Serum creatinine concentration
- Serum potassium concentration
- Serum sodium concentration
- Serum uric acid
- Systolic blood pressure
Show the remaining 1Show the first 8
02 · findings
What pterostilbene moved, and by how much
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Industry funding: named on its row.
9 shown
- Diastolic blood pressureMoved: lowersEvidence: ModeratePaper: PMID 250572762014Industry funded
- Who
- Adults with hypercholesterolemia; high-dose arm only (pterostilbene 125 mg twice daily) against matching placebo, 6-8 weeks
- Dose studied
- pterostilbene 125 mg orally twice daily
There was a significant reduction versus placebo in SBP and DBP with high dose pterostilbene (see Figure 2).”
Quoted verbatim from Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial.RCTPermalink - Serum potassium concentrationMoved: no difference foundEvidence: ModeratePaper: PMID 376714862023
- Who
- Healthy adults aged 18-49 years (PME n = 29 analysed, placebo n = 30); 60 days
- Dose studied
- PME (Silbinol), P. marsupium heartwood extract standardised to 90% pterostilbene, 100 mg capsule twice daily (200 mg/day) after meals
Renal function parameters like urea, uric acid, creatinine, glomerular filtration rate, sodium, potassium, and chloride levels were comparable between placebo and PME at all time points (Table 4 and Table S5, S6).”
Quoted verbatim from A Short-Term Safety Evaluation of Silbinol®- an Extract from Pterocarpus marsupium in Healthy Adults- a Randomized, Double-Blind, Placebo-Controlled Study.RCT · 2 monthsPermalink - Serum uric acidMoved: no difference foundEvidence: ModeratePaper: PMID 376714862023
- Who
- Healthy adults aged 18-49 years (PME n = 29 analysed, placebo n = 30); 60 days
- Dose studied
- PME (Silbinol), P. marsupium heartwood extract standardised to 90% pterostilbene, 100 mg capsule twice daily (200 mg/day) after meals
Renal function parameters like urea, uric acid, creatinine, glomerular filtration rate, sodium, potassium, and chloride levels were comparable between placebo and PME at all time points (Table 4 and Table S5, S6).”
Quoted verbatim from A Short-Term Safety Evaluation of Silbinol®- an Extract from Pterocarpus marsupium in Healthy Adults- a Randomized, Double-Blind, Placebo-Controlled Study.RCT · 2 monthsPermalink - Systolic blood pressureMoved: lowersEvidence: ModeratePaper: PMID 250572762014Industry funded
- Who
- Adults with hypercholesterolemia; high-dose arm only (pterostilbene 125 mg twice daily) against matching placebo, 6-8 weeks
- Dose studied
- pterostilbene 125 mg orally twice daily
There was a significant reduction versus placebo in SBP and DBP with high dose pterostilbene (see Figure 2).”
Quoted verbatim from Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial.RCTPermalink - Serum creatinine concentrationMoved: no difference foundEvidence: ModeratePaper: PMID 376714862023
- Who
- Healthy adults aged 18-49 years (PME n = 29 analysed, placebo n = 30); 60 days
- Dose studied
- PME (Silbinol), P. marsupium heartwood extract standardised to 90% pterostilbene, 100 mg capsule twice daily (200 mg/day) after meals
Renal function parameters like urea, uric acid, creatinine, glomerular filtration rate, sodium, potassium, and chloride levels were comparable between placebo and PME at all time points (Table 4 and Table S5, S6).”
Quoted verbatim from A Short-Term Safety Evaluation of Silbinol®- an Extract from Pterocarpus marsupium in Healthy Adults- a Randomized, Double-Blind, Placebo-Controlled Study.RCT · 2 monthsPermalink - Serum sodium concentrationMoved: no difference foundEvidence: ModeratePaper: PMID 376714862023
- Who
- Healthy adults aged 18-49 years (PME n = 29 analysed, placebo n = 30); 60 days
- Dose studied
- PME (Silbinol), P. marsupium heartwood extract standardised to 90% pterostilbene, 100 mg capsule twice daily (200 mg/day) after meals
Renal function parameters like urea, uric acid, creatinine, glomerular filtration rate, sodium, potassium, and chloride levels were comparable between placebo and PME at all time points (Table 4 and Table S5, S6).”
Quoted verbatim from A Short-Term Safety Evaluation of Silbinol®- an Extract from Pterocarpus marsupium in Healthy Adults- a Randomized, Double-Blind, Placebo-Controlled Study.RCT · 2 monthsPermalink - Alanine aminotransferaseMoved: no difference foundEvidence: ModeratePaper: PMID 376714862023
- Who
- Healthy adults aged 18-49 years (PME n = 29 analysed, placebo n = 30); 60 days
- Dose studied
- PME (Silbinol), P. marsupium heartwood extract standardised to 90% pterostilbene, 100 mg capsule twice daily (200 mg/day) after meals
Parameters of liver function such as total bilirubin, Aspartate transaminase (AST), Alanine transaminase (ALT), and Gamma-glutamyltransferase (GGT) were within the standard reference ranges in subjects supplemented with PME, comparable to the placebo group at the screening, day30 and final visit.”
Quoted verbatim from A Short-Term Safety Evaluation of Silbinol®- an Extract from Pterocarpus marsupium in Healthy Adults- a Randomized, Double-Blind, Placebo-Controlled Study.RCT · 2 monthsPermalink - Aspartate aminotransferaseMoved: no difference foundEvidence: ModeratePaper: PMID 376714862023
- Who
- Healthy adults aged 18-49 years (PME n = 29 analysed, placebo n = 30); 60 days
- Dose studied
- PME (Silbinol), P. marsupium heartwood extract standardised to 90% pterostilbene, 100 mg capsule twice daily (200 mg/day) after meals
Parameters of liver function such as total bilirubin, Aspartate transaminase (AST), Alanine transaminase (ALT), and Gamma-glutamyltransferase (GGT) were within the standard reference ranges in subjects supplemented with PME, comparable to the placebo group at the screening, day30 and final visit.”
Quoted verbatim from A Short-Term Safety Evaluation of Silbinol®- an Extract from Pterocarpus marsupium in Healthy Adults- a Randomized, Double-Blind, Placebo-Controlled Study.RCT · 2 monthsPermalink - Gamma-glutamyl transferaseMoved: no difference foundEvidence: ModeratePaper: PMID 376714862023
- Who
- Healthy adults aged 18-49 years (PME n = 29 analysed, placebo n = 30); 60 days
- Dose studied
- PME (Silbinol), P. marsupium heartwood extract standardised to 90% pterostilbene, 100 mg capsule twice daily (200 mg/day) after meals
Parameters of liver function such as total bilirubin, Aspartate transaminase (AST), Alanine transaminase (ALT), and Gamma-glutamyltransferase (GGT) were within the standard reference ranges in subjects supplemented with PME, comparable to the placebo group at the screening, day30 and final visit.”
Quoted verbatim from A Short-Term Safety Evaluation of Silbinol®- an Extract from Pterocarpus marsupium in Healthy Adults- a Randomized, Double-Blind, Placebo-Controlled Study.RCT · 2 monthsPermalink
No row matches these filters.
No dose is advised.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Industry funding: named on its row.
03 · identity
Structure
- Charge
- 0
- SMILES
- COc1cc(/C=C/c2ccc(O)cc2)cc(OC)c1
04 · on the label · 227 products
Labelled products
Source: NIH DSLD · Ingredient: pterostilbene · 227 products · Declared amount per serving: 0.02–300 mg
143 labels state an amount84 do not
- AbsonutrixPterostilbeneEthanol · suspended in water and ethanol300 mgper 0.59 mLDSLD:322369
- Absorb HealthPterostilbene 100 mg100 mgper 1 capsuleDSLD:216045
- AJS NutritionAJS Brain Pro 20Pterocarpus marsupium · equivalent to 300 mg of raw Pterostilbene powder (Vijayasar)30 mgper 3 capsulesDSLD:329285
- Alive By NatureNAD+ / AMPK ActivatorDimethylresveratrolamount not statedper 2 vegetarian capsulesDSLD:230806
- AN Amazing Nutrition Amazing FormulasPterostilbene 100 mg100 mgper 1 capsuleDSLD:251648
- Applied NutritionBB Skinamount not statedper 2 liquid soft-gelsDSLD:64207
- AptogenixDetox Assist20 mgper 2 capsulesDSLD:323744
- BioSchwartzNootropic Brain Boost10 mgper 1 capsuleDSLD:249903
- BiotiviaPtero MaxPterostilbene, 99%100 mgper 1 vegetarian capsuleDSLD:58351
- BiotiviaPteroActivPterostilbene 98%, 98% Extract yields250 mgper 1 capsuleDSLD:33056
- BluScienceHeart BluPterostilbene, pTeroPure(R50 mgper 1 vegetarian capsuleDSLD:1591
- Bronson LaboratoriesPtero-B50 mgper 1 capsuleDSLD:25472
Show the remaining 215Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
05 · the record
Sources
5
papers screened for pterostilbene
- admitted
- 2
- read and discarded
- 3
- not read yet
- 0
- Documented interactions
- None reported
Sources cited
2 papers · 9 findings